Gene Delivery Systems

Global Market Trajectory & Analytics

MCP16418

EXECUTIVE ENGAGEMENTS

POOL

3029
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

543
Interactions with Platform & by Email

PARTICIPANTS

91
Unique # Participated

VALIDATIONS

26
Responses Validated*

COMPANIES

46
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

171

PAGES

247

EDITION

8

PRICE

USD 4950

CODE

MCP16418


COMPETITIVE METRICS

COMPANY

D S N T

% *

Amgen, Inc.

Login Required

Bayer AG

Login Required

Human Stem Cells Institute

Login Required

Johnson & Johnson Services, Inc.

Login Required

Novartis International AG

Login Required

Oxford BioMedica (UK) Limited

Login Required

Oxford Biomedica PLC

Login Required

Pfizer, Inc.

Login Required

Shanghai Sunway Biotech Co., Ltd.

Login Required

Shenzhen SiBiono GeneTech Co., Ltd.

Login Required

SUBMIT
* D = Dominant; S = Strong; N = Niche; T = Trivial
* Validated respondents are incentivized with cluster data
Note: Best viewed in Landscape Mode
VIEW ENTIRE POOL OF 46 COMPETITORS

Sign-in with email to View Deeper Validated Engagement Details -

  

HIGHLIGHTS & REPORT INDEX

Amid the COVID-19 crisis, the global market for Gene Delivery Systems estimated at US$2.6 Billion in the year 2020, is projected to reach a revised size of US$4 Billion by 2027, growing at aCAGR of 6.4% over the period 2020-2027. Viral Gene Delivery, one of the segments analyzed in the report, is projected to record 6.6% CAGR and reach US$3.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Non-viral Gene Delivery segment is readjusted to a revised 4.7% CAGR for the next 7-year period.
The Gene Delivery Systems market in the U.S. is estimated at US$758.6 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$695.5 Million by the year 2027 trailing a CAGR of 6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6% and 5.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.2% CAGR.

SELECT PLAYERS

Amgen, Inc.; Bayer AG; Human Stem Cells Institute; Johnson & Johnson; Novartis AG; Oxford Biomedica plc; Pfizer, Inc.; Shanghai Sunway Biotech Co., Ltd.; Sibiono GeneTech Co. Ltd.

SEGMENTS

» Application (Infectious Diseases, Oncology, CVD, Urology, CNS, Other Applications) » Delivery (Viral Gene Delivery, Non-viral Gene Delivery) » Route of Administration (Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal, Other Route of Administrations)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Gene Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Gene Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Gene Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
World Current & Future Analysis for Viral Gene Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Viral Gene Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Viral Gene Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Non-viral Gene Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Non-viral Gene Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Non-viral Gene Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Infectious Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for CVD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for CVD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for CVD by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Urology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Urology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Urology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for CNS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for CNS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for CNS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Oral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Injectable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Injectable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Injectable by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Inhalation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Inhalation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Inhalation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Transdermal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Transdermal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Transdermal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Ocular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Ocular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Ocular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Nasal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Nasal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Nasal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Other Route of Administrations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Other Route of Administrations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Route of Administrations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
UNITED STATES
USA Current & Future Analysis for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Gene Delivery Systems by Delivery - Percentage Breakdown of Value Sales for Viral Gene Delivery and Non-viral Gene Delivery for the Years 2012, 2020 & 2027
USA Current & Future Analysis for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Gene Delivery Systems by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications for the Years 2012, 2020 & 2027
USA Current & Future Analysis for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Gene Delivery Systems by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations for the Years 2012, 2020 & 2027
CANADA
Canada Current & Future Analysis for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Gene Delivery Systems by Delivery - Percentage Breakdown of Value Sales for Viral Gene Delivery and Non-viral Gene Delivery for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Gene Delivery Systems by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Gene Delivery Systems by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations for the Years 2012, 2020 & 2027
JAPAN
Japan Current & Future Analysis for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Gene Delivery Systems by Delivery - Percentage Breakdown of Value Sales for Viral Gene Delivery and Non-viral Gene Delivery for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Gene Delivery Systems by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Gene Delivery Systems by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations for the Years 2012, 2020 & 2027
CHINA
China Current & Future Analysis for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Gene Delivery Systems by Delivery - Percentage Breakdown of Value Sales for Viral Gene Delivery and Non-viral Gene Delivery for the Years 2012, 2020 & 2027
China Current & Future Analysis for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Gene Delivery Systems by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications for the Years 2012, 2020 & 2027
China Current & Future Analysis for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Gene Delivery Systems by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations for the Years 2012, 2020 & 2027
EUROPE
Europe Current & Future Analysis for Gene Delivery Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Europe Historic Review for Gene Delivery Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Gene Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
Europe Current & Future Analysis for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Gene Delivery Systems by Delivery - Percentage Breakdown of Value Sales for Viral Gene Delivery and Non-viral Gene Delivery for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Gene Delivery Systems by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Gene Delivery Systems by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations for the Years 2012, 2020 & 2027
FRANCE
France Current & Future Analysis for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Gene Delivery Systems by Delivery - Percentage Breakdown of Value Sales for Viral Gene Delivery and Non-viral Gene Delivery for the Years 2012, 2020 & 2027
France Current & Future Analysis for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Gene Delivery Systems by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications for the Years 2012, 2020 & 2027
France Current & Future Analysis for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Gene Delivery Systems by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations for the Years 2012, 2020 & 2027
GERMANY
Germany Current & Future Analysis for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Gene Delivery Systems by Delivery - Percentage Breakdown of Value Sales for Viral Gene Delivery and Non-viral Gene Delivery for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Gene Delivery Systems by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Gene Delivery Systems by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations for the Years 2012, 2020 & 2027
ITALY
Italy Current & Future Analysis for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Gene Delivery Systems by Delivery - Percentage Breakdown of Value Sales for Viral Gene Delivery and Non-viral Gene Delivery for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Gene Delivery Systems by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Gene Delivery Systems by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations for the Years 2012, 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Gene Delivery Systems by Delivery - Percentage Breakdown of Value Sales for Viral Gene Delivery and Non-viral Gene Delivery for the Years 2012, 2020 & 2027
UK Current & Future Analysis for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Gene Delivery Systems by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications for the Years 2012, 2020 & 2027
UK Current & Future Analysis for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Gene Delivery Systems by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations for the Years 2012, 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Gene Delivery Systems by Delivery - Percentage Breakdown of Value Sales for Viral Gene Delivery and Non-viral Gene Delivery for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Gene Delivery Systems by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Gene Delivery Systems by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations for the Years 2012, 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Gene Delivery Systems by Delivery - Percentage Breakdown of Value Sales for Viral Gene Delivery and Non-viral Gene Delivery for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Gene Delivery Systems by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Gene Delivery Systems by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations for the Years 2012, 2020 & 2027
REST OF WORLD
Rest of World Current & Future Analysis for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Gene Delivery Systems by Delivery - Viral Gene Delivery and Non-viral Gene Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Gene Delivery Systems by Delivery - Percentage Breakdown of Value Sales for Viral Gene Delivery and Non-viral Gene Delivery for the Years 2012, 2020 & 2027
Rest of World Current & Future Analysis for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Gene Delivery Systems by Application - Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Gene Delivery Systems by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, CVD, Urology, CNS and Other Applications for the Years 2012, 2020 & 2027
Rest of World Current & Future Analysis for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Gene Delivery Systems by Route Of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Gene Delivery Systems by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal and Other Route of Administrations for the Years 2012, 2020 & 2027
Total Companies Profiled: 46

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com